Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

Bactiguard appoints new CEO

The Board of Bactiguard Holding AB (publ) has today appointed Anders Göransson as the new CEO. Anders has extensive experience from consulting within McKinsey and has held several senior positions in Amgen, most recently as Head of Innovation Europe. Anders will start his employment in Bactiguard...

2021-09-08 09:51 3093

NCCN Shares Latest Expert Recommendations for Prostate Cancer in Spanish and Portuguese

PLYMOUTH MEETING, Pa., Sept. 8, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—a nonprofit alliance of leading cancer centers in the United States—announces recently-updated versions of evidence- and expert consensus-based guidelines for treating prostate cancer,translate...

2021-09-08 09:37 2223

Gannex Announces Positive Topline Results from the U.S. Phase I Trial of Drug-Drug Interactions in Healthy Subjects and Pharmacokinetics in Patients with NAFLD for Its THRβ Agonist ASC41

SHANGHAI, Sept. 8, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), today announces positive topline results from the U.S. Phase I trial of drug-drug interactions in healthy subjects and pharmacokinetics (PK) in patients with non-alcoholic fatty liver dise...

2021-09-08 08:30 4405

Innovent Announces First Patient with Type 2 Diabetes Dosed in a Phase 2 Clinical Trial of IBI362 (a GLP-1R and Glucagon Receptor Dual Agonist) in China

SAN FRANCISCO and SUZHOU, China, Sept. 8, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...

2021-09-08 08:00 8326

Stem Cells for Everyone: I Peace expands its clinical-grade iPSC banking service leveraging mass manufacturing capability

PALO ALTO, Calif., Sept. 7, 2021 /PRNewswire/ -- I Peace, Inc. (CEO: Koji Tanabe , https://ipeace.com/), aPalo Alto-based biotech startup focusing on Nobel Prize-winning technology of induced pluripotent stem cells (iPSCs) expands its personalized iPSC banking service. I Peace launched its clinica...

2021-09-08 02:00 2000

First-of-its-Kind, Global Data Repository for Interstitial Lung Diseases Launches Through Academic and Industry Collaborative

HOLLAND, Mich., Sept. 7, 2021 /PRNewswire/ -- The Open Source Imaging Consortium (OSIC) today announced the launch of its global, data-rich repository of anonymized HRCT scans and clinical information regarding interstitial lung diseases (ILDs). This first-of-its-kind database is the world's lar...

2021-09-07 23:00 3938

Further Study in humans shows that the DTH response, the basis for CoviDTH, is highly durable and persists for at least one year after COVID-19 exposure or vaccine administration

VANCOUVER, BC and SAN CRISTÓBAL DE LA LAGUNA, Spain, Sept. 7, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "the Company") is pleased to announce that the Scientific Advisor for its CoviDTH program,Yvelise Barrios, MD, PhD, and Clinical Immuno...

2021-09-07 20:00 7105

Medwish.com Launches Global Free Shipping Plan to Deliver Medical Equipment to Hospitals

SHANGHAI, Sept. 7, 2021 /PRNewswire/ -- Medwish.com, the online B2B medical equipment marketplace, today announced it will offer free shipping on more than 10,000 medical products in its full 14 sub-categories covering hospital beds, patient monitors, compressor nebulizers, oxygen concentrators, ...

2021-09-07 19:26 3263

Medwish.com Launches Global Free Shipping Plan to Deliver Medical Equipment to Hospitals

Brii Biosciences Adds US$100 Million to Advance its Late-Stage Monoclonal Antibody Combination Therapy, BRII-196/BRII-198, for Non-Hospitalized COVID-19 Patients

DURHAM, N.C. and BEIJING, Sept. 7, 2021 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public healt...

2021-09-07 19:04 5863

RedHill Biopharma's Opaganib Demonstrates Significant Decrease of Kidney Fibrosis

- COVID-19 and long COVID patients are at increased risk of developing kidney damage - Opaganib significantly decreased kidney fibrosis in a preclinical in vivo model - Renal fibrosis is a progressive process which occurs in patients with chronic kidney disease (CKD) and can ultimately lead to ...

2021-09-07 19:00 3587

Insilico Medicine and University of Cambridge Announce a Collaboration on Target Identification for Human Diseases Linked to Protein Liquid-liquid Phase Separation

HONG KONG, Sept. 7, 2021 /PRNewswire/ -- Insilico Medicine, an end-to-end artificial intelligence (AI) -driven drug discovery company, specialized in target discovery, small molecule chemistry, and clinical development, announced a collaboration with theUniversity of Cambridge. The agreement out...

2021-09-07 18:15 3548

Ethics Approval Granted for Clinical Trial of World's First Nasal Swab Designed Specifically for Children

* Rhinomed has created the world's first nasal swab designed specifically for children — The Rhinoswab Junior™ * Ethics approval has been received for a clinical trial to commence with the Murdoch Children's Research Institute (MCRI) at The Royal Children's Hospital in Melbourne * Trial seek...

2021-09-07 18:00 2925

RedHill Biopharma Presents Three New Analyses of Movantik Data at PAINWeek 2021

- Two new analyses of Movantik® (naloxegol) data evaluated the safety and efficacy of Movantik in a subgroup of patients aged ≥ 65 years - Analysis of Movantik effects on rapid and sustained improvement of both spontaneous and complete spontaneous bowel movements in the Movantik group vs. placeb...

2021-09-07 18:00 4479

Jubilant Biosys Limited announces the appointment of Mr. Giuliano Perfetti as Chief Executive Officer

BENGALURU, India, Sept. 7, 2021 /PRNewswire/ -- Today, Jubilant Biosys Limited announced the appointment ofGiuliano Perfetti as its Chief Executive Officer. Mr. Giuliano Perfetti joins as CEO Jubilant Bio...

2021-09-07 16:11 6080

Jubilant Biosys Limited announces the appointment of Mr. Giuliano Perfetti as Chief Executive Officer

MIM Software Inc. Announces AI Segmentation and Single Timepoint Dosimetry Capabilities for Molecular Radiotherapy

CLEVELAND, Sept. 7, 2021 /PRNewswire/ -- MIM Software Inc., a leading global provider of medical imaging software, announced today new innovations to MIM SurePlan™ MRT, its software package for Molecular Radiotherapy. MIM SurePlan MRT has received CE Mark approval for new artificial intelligence...

2021-09-07 15:00 4010

NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease

-- Using NeuExcell's neuroregenerative gene therapy platform, the collaboration aims to develop an effective and safe treatment for patients suffering from Huntington's Disease. -- Spark Therapeutics' excellence in R&D and proprietary adeno-associated virus (AAV) vector gene therapy platform ma...

2021-09-07 12:00 4387

Major new study reveals that half of all people fear the internet and smartphones are damaging wellbeing

DHAHRAN, Saudi Arabia, Sept. 7, 2021 /PRNewswire/ -- As the world adjusts to a post-pandemic reality dominated by technology, public concerns about the dangers of over-consumption are gathering pace. According to a major new survey[1] from Saudi-based cultural institute,Ithra

2021-09-07 08:01 5712

JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in China

* The first CAR-T product independently developed in China and approved as a Category 1 biologics product, and the sixth approved CAR-T product globally * Currently the only approved CAR-T product that has been simultaneously included in the National Significant New Drug Development Program, g...

2021-09-06 19:03 6020

GenScript ProBio Enters into Agreement with SYNIMMUNE for Manufacturing of their Innovative Antibody Drug

NANJING, China, Sept. 6, 2021 /PRNewswire/ -- GenScript ProBio is delighted to announce the signing of a manufacturing service agreement for Synimmune's innovative FLYSYN antibody project for clinical Phase II production. FLYSYN is a fms-like tyrosine kinase 3 (FLT3) specific antibody for the ...

2021-09-06 16:00 3599

Inspiration Capital Partners announces Investment in Beijing Loving Care International Pet Medical Center

SHANGHAI, Sept. 6, 2021 /PRNewswire/ -- Inspiration Capital Partners ("ICP") today announced an investment in Beijing Loving Care International Pet Medical Center ("Loving Care"). Founded in 2013, Loving Care is a leading premium specialty pet healthcare chain, focusing on providing high quality...

2021-09-06 15:32 4060

1 ... 621 622 623624625 626 627 ... 649